Why Gilead Stock Lagged Behind Other Biotechs In April
What happened
According to data from S&P Global Market Intelligence, Gilead Sciences (NASDAQ:GILD) stock gained only 0.98% in April, despite the rest of the industry having yet another fairly strong month. The iShares Nasdaq Biotechnology Index (NASDAQ:IBB), for instance, gained 2.29% last month.
According to data from S&P Global Market Intelligence, Gilead Sciences (NASDAQ:GILD) stock gained only 0.98% in April, despite the rest of the industry having yet another fairly strong month. The iShares Nasdaq Biotechnology Index (NASDAQ:IBB), for instance, gained 2.29% last month.